An Integrative and Intuitive Map to an Investigation Prescription Monitoring Programs:
-
Upload
agnes-powell -
Category
Documents
-
view
218 -
download
0
description
Transcript of An Integrative and Intuitive Map to an Investigation Prescription Monitoring Programs:
An Integrative and Intuitive Map
to an Investigation
Prescription Monitoring Programs:
Janeen Dahn Ph.D., FNP-CArizona State Board of
Nursing
Objectives
Following this presentation, you will…• Identify issues with overuse, misuse,
and abuse of controlled substances• Analyze the PDMP• Integrate PDMP data with healthcare
records• Recognize the limitations of the PDMP
Why Do We Care?• Opioids are the most widely misused or abused
Rx and are involved in most Rx related overdoses• In 2009, non medical users of psychotherapeutics
(prescription opioid pain relievers, tranquilizers, sedatives, and stimulants) were similar to #s of 1st time Marijuana users
Office of National Drug Control Policy. (2011) Retrieved from https://www.whitehouse.gov/ondcp/ondcp-fact-sheets/prescription-drug-monitoring-programs
Why Do We Care?
• In 2010, 6 of the top 10 substances used by 12th graders were pharmaceuticals • In 17 states drug-induced deaths are now the
leading cause of injury death https://www.whitehouse.gov/sites/default/files/ondcp/Fact_Sheets/pdmp_fact_sheet_4-8-11.pdf
Why Do We Care?• In 2013 ~ 2 Million Americans abused Rx pain meds• Most common drugs in overdose deaths include:• Hydrocodone (e.g. Vicodin)• Oxycodone (e.g. OxyContin, Percocet)• Oxymorphone (e.g. Opana)• Methadone (especially when prescribed for pain)
• Between 1997 -2007 treatment admissions for overdose increased 4 fold.
Statistics
• 70% of people who abused prescription pain relievers got them from friends or relatives
• Data from the National Survey on Drug Use and Health show that nearly 1/3 of people aged 12 and over who used drugs for the first time in 2009, began using a prescription drug non-medically http://www.whitehouse.gov/ondcp/prescription-drug-abuse
• Each day, almost 7,000 people are treated in the ER for RX overdose
Nationwide…
• Approximately 15,000 people died every year from overdoses involving prescription pain killers, more than those who die from heroin and cocaine combined. Center for Disease Control and prevention (2013). Prescription Painkiller Overdoses in the U.S. Retrieved from http://www.cdc.gov/Features/VitalSigns/PainkillerOverdoses/index.html
• 15,000 died in 2008 – more than triple the 4,000 people killed by prescription drugs in 1999 Center for Disease Control and prevention (2013). Prescription Painkiller Overdoses in the U.S. Retrieved from http://www.cdc.gov/Features/VitalSigns/PainkillerOverdoses/index.html
Why Do We (as regulators) Care?
• Healthcare provider with active/untreated substance abuse disorder (SUD) puts patients at risk• Reckless prescribing to persons with SUD or
sell/provide the drugs to others puts the public at risk
Street Value• Oxycodone 30mg = $30/each• Percocet = $1 per mg• OxyContin 80mg = $80/each• Methadone = $5 - $10/each• Hydrocodone (Vicodin) = $3 - $10/each
PDMP - What is it?• Prescription Drug Monitoring Programs (PDMP)• Controlled Substance Utilization Review and
Evaluation System (CURES)• Prescription Monitoring Program (PMP)• Controlled Substance Prescription Monitoring
Program (CSPMP)• Controlled Substance Database Program (CSD)• Michigan Automated Prescription System
(MAPS)• Kentucky All Schedule Prescription Electronic
Reporting (KASPER)
Who Uses the PDMP?• Statutory authority• Originally developed for law enforcement to identify
patterns of misuse, diversion, or excessive prescribing • Prescribers• Regulators• Pharmacists
• Training• Credentials• Registration• Tutorial
Identify how to access the PDMP
Authorized Recipients – Licensing/Regulatory Boards
© 2015 Research is current as of December 2014. In order to ensure that the information contained herein is as current as possible, research is conducted using both nationwide legal database software and individual state legislative websites and direct communications with state PMP administrators. Please contact Heather Gray at (703) 836-6100, ext. 114 or [email protected] with any additional updates or information that may be relevant to this document. This document is intended for educational purposes only and does not constitute legal advice or opinion. Headquarters Office: THE NATIONAL ALLIANCE FOR MODEL STATE DRUG LAWS, 420 Park Street, Charlottesville, VA 22902.
Morphine Equivalency Dosing (MED)
• System to equate different opiates and potencies into a standard morphine equivalent value• Conversion chart created by Center for
Disease Control (CDC) • For each ACTIVE prescription then combined
into one daily MED value • “Press Pause” at 100 MED
Analyze the PDMP
How to use the PDMP?Must have a NEXUS to the case
• For the Respondent who is a patient (Respondent’s prescription profile)• Unusual behavior/impaired/DUI
• For the Respondent who is a provider• Prescribing concerns
• The PDMP is a TOOL used to address prescription drug diversion, misuse, and abuse. • Doctor shopping• Patterns of inappropriate prescribing
Analyzing the PDMP• Red Flags for Patient Investigation• Multiple pharmacies• Multiple providers• Escalating dosages• Multiple address• Similar birthdates• Pattern of early refills• Cash pay• Volume and dose• Street value?• Multiple substances• Oxycodone 30mg• Back pain?
New And Old OxyContin Pills
80-milligram tablets of the current OxyContin formula (left) and the previous OxyContin formula (right)
Old vs. New
The pre-2010 OxyContin pill crushes into grains (left) while the newer formula is more difficult to break up (right).
Analyzing the PDMP• Red Flags for Prescriber Investigation• Multiple pharmacies• Multiple providers• Escalating dosages• Early refills• High dosages high volumes• Family members of patient or provider• Same med – Oxycontin 30mg• “Pill mill”
Integrate PDMP data with healthcare records
Integrate PDMP Data with Healthcare Records
• Personal Characteristics of Patient • Prescription not consistent with diagnostic
evidence• Doctor hopping • Different names with same address• Family members getting same drug
• UDS not consistent with prescriptions• Excuses for lost/stolen prescriptions• Early refills• Ping ponging between drugs• Request for specific meds/higher doses
Personal Characteristics of Patient
• Employment issues:• “Documentation” errors• Frequent absences • ER/ICU (frequent and high drug usage)• Nights/weekends/overtime• DUI • Legal issues
• What type of providers are they seeing?• Are they impaired? Or do they have other
medical issues?
Integrate PDMP Data with Healthcare Records
• Characteristics of Prescriber Investigation• Replacement Rx• Sloppy documentation/template• High pain pt population (not consistent with
specialty)• High daily pt volume• Communication with other providers?• Response to PMP unexpected findings• UDS and results
Personal Characteristics of Provider• Characteristics of Prescriber
Investigation• Lack of Knowledge ? Or
Misuse/Abuse and/or Sale?• Pain agreement• Consistent with national guidelines• Cash visits• Same drug over and over• Law enforcement and DEA interest• Consistent with genuine medical office• (no sign out front, voice mail only)
Standard of CareStandard of Care # 1 Prescribing Long-Term Opioid Medications:Prior to prescribing long-term opioid medications for chronic non-malignant pain, it is standard of care for an NP to conduct an appropriate evaluation of the pain problem and identify the pain generator. This evaluation includes the NP taking a pain history, reviewing the patient’s medical records, conducting a targeted physical exam, taking a drug history including verification of current prescriptions, and considering concomitant medical/psychiatric problems that may impact pain management. Each patient’s treatment plan should be individualized, and include consideration of a multidisciplinary approach/collaboration with other medical experts, as appropriate
Standard of Care
Deviation of Standard of Care #1From on or about xxxxxx through xxxxx Respondent treated patient XX for Chronic pain with long-term opioid medications. The medical record fails to demonstrate that Respondent conducted an appropriate evaluation of the pain problem, which identified the pain generator. This medical record lacks evidence that Respondent took a pain history, reviewed the patient’s medical records, or conducted a targeted physical exam…
Standard of Care
Standard of Care # 2 Periodic Urine Drug ScreeningEvaluation of the chronic pain patient should include periodic urine drug screen testing to detect the presence of the prescribed medications and presence of illegal or illicit substances.
Understand how to use the PDMP
How to use the PDMP• Identify Nexus• Remember it is just a tool in
the investigation to find supporting evidence• Identify concerning prescribing
patterns• Obtain a copy of original
prescription with provider signature
• Compare signatures• Verify quantities• Verify the medication was actually picked
up• Request medical records• Request prescription profiles from
pharmacy/insurance• Compare PDMP to medical record
How to use the PDMP• PMP During an Interview with
prescriber• “What is your practice when
prescribing…”• Step dosing, quantities, combinations• If deviation, show PMP• REMEMBER THE PMP IS JUST A TOOL
How to use the PDMP• PMP During an Interview with
Patient• What medications have been
prescribed to you and by who?• How often? How many providers?• What for?• Show patient PMP if the story
doesn’t fit• REMEMBER THE PMP IS JUST A
TOOL
Recognize the limitations of the PDMP
Recognize the limitations of the PDMP
• Who contributes and who does not• Dispensing from office• Federal facilities• Methadone clinics
• Federal healthcare facilities (e.g. Department of Veterans Affairs, Department of Defense, and Indian Health Service) are not required and do not generally report to state PDMPs
Recognize the limitations of the PDMP
• Human error• Illegible prescriber name ? Correct
prescriber• “Date filled”• Up to a 2-week lag in data entry• State Borders
SummaryPutting the pieces together
• Identify issues with overuse, misuse, and abuse of controlled substances•Analyze the PDMP• Integrate PDMP data with healthcare
records•Recognize the limitations of the PDMP
Questions? Comments?
Janeen Dahn PhD, FNP-C email: [email protected]